Bannerman Wealth Management Group, LLC Alnylam Pharmaceuticals, Inc. Transaction History
Bannerman Wealth Management Group, LLC
- $141 Billion
- Q4 2025
A detailed history of Bannerman Wealth Management Group, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Bannerman Wealth Management Group, LLC holds 1,947 shares of ALNY stock, worth $874,514. This represents 0.55% of its overall portfolio holdings.
Number of Shares
1,947
Previous 2,047
4.89%
Holding current value
$874,514
Previous $933 Million
17.06%
% of portfolio
0.55%
Previous 0.69%
Shares
5 transactions
Others Institutions Holding ALNY
# of Institutions
916Shares Held
117MCall Options Held
1.25MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA16.4MShares$7.38 Billion1.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$6.09 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.29 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.22MShares$3.24 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY4.54MShares$2.04 Billion0.14% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $55.3B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...